Reply to why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion

Affiliations

Free article

Comment

Douglas S Rabin. Cancer Cytopathol. 2016 Jan.

Free article

. 2016 Jan;124(1):68-9.

doi: 10.1002/cncy.21621. Epub 2015 Sep 10.

No abstract available

Comment on

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Blatt AJ, et al. Cancer Cytopathol. 2015 May;123(5):282-8. doi: 10.1002/cncy.21544. Epub 2015 Apr 10. Cancer Cytopathol. 2015. PMID: 25864682 Free PMC article.
Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.
Rossi PG, Ronco G, Dillner J, Elfström KM, Snijders PJ, Arbyn M, Berkhof J, Carozzi F, Del Mistro A, De Sanjosè S, Bosch X, Petry KU, Poljak M, Naldoni C, Meijer CJ; Comparing Health Services Interventions for the Prevention of HPV-Related Cancer Consortium; New Technologies for Cervical Cancer Group. Rossi PG, et al. Cancer Cytopathol. 2016 Jan;124(1):66-7. doi: 10.1002/cncy.21622. Epub 2015 Sep 10. Cancer Cytopathol. 2016. PMID: 26356132 No abstract available.